| 1 | [SID48415349] | Active | | | DSSTox (EPAFHM) EPA Fathead Minnow Acute Toxicity [AID1188, Type: other] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 48415349 | | CID | 2566 | | Outcome | Active | | BioAssay | DSSTox (EPAFHM) EPA Fathead Minnow Acute Toxicity | | AID | 1188 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID103223482] | Unspecified | | | In vitro insecticidal activity in bovine serum against adult stable fly [AID33089, Type: Literature] | |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103223482 | | CID | 2566 | | Outcome | Unspecified | | BioAssay | In vitro insecticidal activity in bovine serum against adult stable fly | | AID | 33089 | | BioAssay type | Literature | | Target | | | PubMed | 2769686 | | Data Table |  |
|
| 3 | [SID103223482] | Unspecified | | | In vitro insecticidal activity in bovine serum against Blowfly larvae [AID42466, Type: Literature] | |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103223482 | | CID | 2566 | | Outcome | Unspecified | | BioAssay | In vitro insecticidal activity in bovine serum against Blowfly larvae | | AID | 42466 | | BioAssay type | Literature | | Target | | | PubMed | 2769686 | | Data Table |  |
|
| 4 | [SID103223482] | Unspecified | | | Binding energy by using the equation deltaG obsd = -RT ln KD [AID227718, Type: Literature] | |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103223482 | | CID | 2566 | | Outcome | Unspecified | | BioAssay | Binding energy by using the equation deltaG obsd = -RT ln KD | | AID | 227718 | | BioAssay type | Literature | | Target | | | PubMed | 6094812 | | Data Table |  |
|
| 5 | [SID103223482] | Unspecified | | | Nematicidal activity against Meloidogyne incognita assessed as larval mortality at 1% drug concentration after 24 hrs [AID380390, Type: Literature] | |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103223482 | | CID | 2566 | | Outcome | Unspecified | | BioAssay | Nematicidal activity against Meloidogyne incognita assessed as larval mortality at 1% drug concentration after 24 hrs | | AID | 380390 | | BioAssay type | Literature | | Target | | | PubMed | 10869197 | | Data Table |  |
|
| 6 | [SID103223482] | Unspecified | | | Nematicidal activity against Meloidogyne incognita assessed as larval mortality at 1% drug concentration after 48 hrs [AID380391, Type: Literature] | |   View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103223482 | | CID | 2566 | | Outcome | Unspecified | | BioAssay | Nematicidal activity against Meloidogyne incognita assessed as larval mortality at 1% drug concentration after 48 hrs | | AID | 380391 | | BioAssay type | Literature | | Target | | | PubMed | 10869197 | | Data Table |  |
|
| 7 | [SID103223482] | Unspecified | | | Nematicidal activity against Meloidogyne incognita assessed as larval mortality at 1% drug concentration after 72 hrs [AID380392, Type: Literature] | |   View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103223482 | | CID | 2566 | | Outcome | Unspecified | | BioAssay | Nematicidal activity against Meloidogyne incognita assessed as larval mortality at 1% drug concentration after 72 hrs | | AID | 380392 | | BioAssay type | Literature | | Target | | | PubMed | 10869197 | | Data Table |  |
|
| 8 | [SID103223482] | Unspecified | | | Inhibition of Anopheles gambiae AChE expressed in Escherichia coli after 6 mins by Ellman assay [AID671039, Type: Literature] | |   View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103223482 | | CID | 2566 | | Outcome | Unspecified | | BioAssay | Inhibition of Anopheles gambiae AChE expressed in Escherichia coli after 6 mins by Ellman assay | | AID | 671039 | | BioAssay type | Literature | | Target | | | PubMed | 22738634 | | Data Table |  |
|
| 9 | [SID103223482] | Unspecified | | | Toxicity in Anopheles gambiae G3 assessed as mortality treated as tarsal contact using dried filter papers after 24 hrs [AID671042, Type: Literature] | |   View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103223482 | | CID | 2566 | | Outcome | Unspecified | | BioAssay | Toxicity in Anopheles gambiae G3 assessed as mortality treated as tarsal contact using dried filter papers after 24 hrs | | AID | 671042 | | BioAssay type | Literature | | Target | | | PubMed | 22738634 | | Data Table |  |
|
| 10 | [SID103223482] | Unspecified | | | Toxicity in anesthetized Anopheles gambiae G3 assessed as mortality treated as topical application assessed per mosquito after 24 hrs [AID671043, Type: Literature] | |   View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103223482 | | CID | 2566 | | Outcome | Unspecified | | BioAssay | Toxicity in anesthetized Anopheles gambiae G3 assessed as mortality treated as topical application assessed per mosquito after 24 hrs | | AID | 671043 | | BioAssay type | Literature | | Target | | | PubMed | 22738634 | | Data Table |  |
|
| 11 | [SID103223482] | Unspecified | | | Inhibition of Anopheles gambiae AChE [AID671037, Type: Literature] | |   View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103223482 | | CID | 2566 | | Outcome | Unspecified | | BioAssay | Inhibition of Anopheles gambiae AChE | | AID | 671037 | | BioAssay type | Literature | | Target | | | PubMed | 22738634 | | Data Table |  |
|
| 12 | [SID103223482] | Unspecified | | | Inhibition of human recombinant AChE after 6 mins by Ellman assay [AID671040, Type: Literature] | |   View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 103223482 | | CID | 2566 | | Outcome | Unspecified | | BioAssay | Inhibition of human recombinant AChE after 6 mins by Ellman assay | | AID | 671040 | | BioAssay type | Literature | | Target | | | PubMed | 22738634 | | Data Table |  |
|
| 13 | [SID103223482] | Unspecified | | | Selectivity ratio of Ki for Anopheles gambiae AChE to Ki for human recombinant AChE [AID671041, Type: Literature] | |   View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103223482 | | CID | 2566 | | Outcome | Unspecified | | BioAssay | Selectivity ratio of Ki for Anopheles gambiae AChE to Ki for human recombinant AChE | | AID | 671041 | | BioAssay type | Literature | | Target | | | PubMed | 22738634 | | Data Table |  |
|
| 14 | [SID103223482] | Unspecified | | | Inhibition of human FAAH at 1 uM [AID468443, Type: Literature] | Fatty-acid amide hydrolase 1 [gi:60416391] |   View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103223482 | | CID | 2566 | | Outcome | Unspecified | | BioAssay | Inhibition of human FAAH at 1 uM | | AID | 468443 | | BioAssay type | Literature | | Target | Fatty-acid amide hydrolase 1 [gi:60416391] | | PubMed | 19850474 | | Data Table |  |
|
| 15 | [SID26747753] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate [AID2112, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 26747753 | | CID | 2566 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate | | AID | 2112 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 16 | [SID26747753] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate [AID2112, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 26747753 | | CID | 2566 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate | | AID | 2112 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 17 | [SID26747753] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate [AID2112, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 26747753 | | CID | 2566 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate | | AID | 2112 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 18 | [SID26747753] | Inactive | | | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen [AID2472, Type: screening] | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 26747753 | | CID | 2566 | | Outcome | Inactive | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen | | AID | 2472 | | BioAssay type | screening | | Target | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] | | PubMed | | | Data Table |  |
|
| 19 | [SID26747753] | Inactive | | | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen [AID2472, Type: screening] | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 26747753 | | CID | 2566 | | Outcome | Inactive | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen | | AID | 2472 | | BioAssay type | screening | | Target | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] | | PubMed | | | Data Table |  |
|
| 20 | [SID26747753] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease [AID2101, Type: confirmatory] | glucocerebrosidase [Homo sapiens] [gi:496369] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 26747753 | | CID | 2566 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease | | AID | 2101 | | BioAssay type | confirmatory | | Target | glucocerebrosidase [Homo sapiens] [gi:496369] | | PubMed | | | Data Table |  |
|
| 21 | [SID26747753] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease [AID2101, Type: confirmatory] | glucocerebrosidase [Homo sapiens] [gi:496369] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 26747753 | | CID | 2566 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease | | AID | 2101 | | BioAssay type | confirmatory | | Target | glucocerebrosidase [Homo sapiens] [gi:496369] | | PubMed | | | Data Table |  |
|
| 22 | [SID26747753] | Inactive | Potency | | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 26747753 | | CID | 2566 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 23 | [SID26747753] | Inactive | Potency | | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 26747753 | | CID | 2566 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 24 | [SID26747753] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate [AID2107, Type: confirmatory] | alpha-galactosidase [Homo sapiens] [gi:757912] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 26747753 | | CID | 2566 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate | | AID | 2107 | | BioAssay type | confirmatory | | Target | alpha-galactosidase [Homo sapiens] [gi:757912] | | PubMed | | | Data Table |  |
|
| 25 | [SID26747753] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate [AID2107, Type: confirmatory] | alpha-galactosidase [Homo sapiens] [gi:757912] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 26747753 | | CID | 2566 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate | | AID | 2107 | | BioAssay type | confirmatory | | Target | alpha-galactosidase [Homo sapiens] [gi:757912] | | PubMed | | | Data Table |  |
|
| 26 | [SID26747753] | Inactive | Potency | | qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5. [AID1467, Type: confirmatory] | alpha-galactosidase [Homo sapiens] [gi:757912] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 26747753 | | CID | 2566 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5. | | AID | 1467 | | BioAssay type | confirmatory | | Target | alpha-galactosidase [Homo sapiens] [gi:757912] | | PubMed | | | Data Table |  |
|
| 27 | [SID26747753] | Inactive | Potency | | qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5. [AID1467, Type: confirmatory] | alpha-galactosidase [Homo sapiens] [gi:757912] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 26747753 | | CID | 2566 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5. | | AID | 1467 | | BioAssay type | confirmatory | | Target | alpha-galactosidase [Homo sapiens] [gi:757912] | | PubMed | | | Data Table |  |
|
| 28 | [SID26747753] | Inactive | Potency | | Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 705 locus [AID930, Type: confirmatory] | hemoglobin subunit beta [Homo sapiens] [gi:4504349] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 26747753 | | CID | 2566 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 705 locus | | AID | 930 | | BioAssay type | confirmatory | | Target | hemoglobin subunit beta [Homo sapiens] [gi:4504349] | | PubMed | | | Data Table |  |
|
| 29 | [SID26747753] | Inactive | Potency | | Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 654 locus [AID910, Type: confirmatory] | hemoglobin subunit beta [Homo sapiens] [gi:4504349] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 26747753 | | CID | 2566 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 654 locus | | AID | 910 | | BioAssay type | confirmatory | | Target | hemoglobin subunit beta [Homo sapiens] [gi:4504349] | | PubMed | | | Data Table |  |
|
| 30 | [SID26747753] | Inactive | Potency | | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) [AID894, Type: confirmatory] | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 26747753 | | CID | 2566 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) | | AID | 894 | | BioAssay type | confirmatory | | Target | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] | | PubMed | | | Data Table |  |
|
| 31 | [SID26747753] | Inactive | Potency | | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) [AID894, Type: confirmatory] | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 26747753 | | CID | 2566 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) | | AID | 894 | | BioAssay type | confirmatory | | Target | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] | | PubMed | | | Data Table |  |
|
| 32 | [SID26747753] | Inactive | Potency | | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) [AID894, Type: confirmatory] | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 26747753 | | CID | 2566 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) | | AID | 894 | | BioAssay type | confirmatory | | Target | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] | | PubMed | | | Data Table |  |
|
| 33 | [SID26747753] | Inactive | Potency | | qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent) [AID1476, Type: confirmatory] | Chain A, Crystal Structure Of Cruzain Covalently Bound To A Purine Nitrile [gi:281307097] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 26747753 | | CID | 2566 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent) | | AID | 1476 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of Cruzain Covalently Bound To A Purine Nitrile [gi:281307097] | | PubMed | | | Data Table |  |
|
| 34 | [SID26747753] | Inactive | Potency | | qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent) [AID1478, Type: confirmatory] | Chain A, Crystal Structure Of Cruzain Covalently Bound To A Purine Nitrile [gi:281307097] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 26747753 | | CID | 2566 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent) | | AID | 1478 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of Cruzain Covalently Bound To A Purine Nitrile [gi:281307097] | | PubMed | | | Data Table |  |
|
| 35 | [SID26747753] | Inactive | Potency | | qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) [AID2549, Type: confirmatory] | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 26747753 | | CID | 2566 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) | | AID | 2549 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] | | PubMed | | | Data Table |  |
|
| 36 | [SID26747753] | Inactive | Potency | | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 26747753 | | CID | 2566 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 37 | [SID26747753] | Inactive | Potency | | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 26747753 | | CID | 2566 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 38 | [SID26747753] | Inactive | Potency | | qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase) [AID1452, Type: confirmatory] | arachidonate 12-lipoxygenase, 12S-type [Homo sapiens] [gi:154426292] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 26747753 | | CID | 2566 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase) | | AID | 1452 | | BioAssay type | confirmatory | | Target | arachidonate 12-lipoxygenase, 12S-type [Homo sapiens] [gi:154426292] | | PubMed | | | Data Table |  |
|
| 39 | [SID26747753] | Inactive | Potency | | qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase) [AID1452, Type: confirmatory] | arachidonate 12-lipoxygenase, 12S-type [Homo sapiens] [gi:154426292] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 26747753 | | CID | 2566 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase) | | AID | 1452 | | BioAssay type | confirmatory | | Target | arachidonate 12-lipoxygenase, 12S-type [Homo sapiens] [gi:154426292] | | PubMed | | | Data Table |  |
|
| 40 | [SID26747753] | Inactive | Potency | | qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase) [AID887, Type: confirmatory] | 15-lipoxygenase [Homo sapiens] [gi:1832253] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 26747753 | | CID | 2566 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase) | | AID | 887 | | BioAssay type | confirmatory | | Target | 15-lipoxygenase [Homo sapiens] [gi:1832253] | | PubMed | | | Data Table |  |
|
| 41 | [SID26747753] | Inactive | Potency | | qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase) [AID887, Type: confirmatory] | 15-lipoxygenase [Homo sapiens] [gi:1832253] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 26747753 | | CID | 2566 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase) | | AID | 887 | | BioAssay type | confirmatory | | Target | 15-lipoxygenase [Homo sapiens] [gi:1832253] | | PubMed | | | Data Table |  |
|
| 42 | [SID26747753] | Inactive | Potency | | qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2) [AID881, Type: confirmatory] | Arachidonate 15-lipoxygenase B [gi:317373425] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 26747753 | | CID | 2566 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2) | | AID | 881 | | BioAssay type | confirmatory | | Target | Arachidonate 15-lipoxygenase B [gi:317373425] | | PubMed | | | Data Table |  |
|
| 43 | [SID26747753] | Inactive | Potency | | qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM) [AID2528, Type: confirmatory] | Bloom syndrome protein [Homo sapiens] [gi:4557365] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 26747753 | | CID | 2566 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM) | | AID | 2528 | | BioAssay type | confirmatory | | Target | Bloom syndrome protein [Homo sapiens] [gi:4557365] | | PubMed | | | Data Table |  |
|
| 44 | [SID26747753] | Inactive | Potency | | qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1 [AID900, Type: confirmatory] | caspase-1 isoform alpha precursor [Homo sapiens] [gi:15431328] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 26747753 | | CID | 2566 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1 | | AID | 900 | | BioAssay type | confirmatory | | Target | caspase-1 isoform alpha precursor [Homo sapiens] [gi:15431328] | | PubMed | | | Data Table |  |
|
| 45 | [SID26747753] | Inactive | Potency | | qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1 [AID900, Type: confirmatory] | caspase-1 isoform alpha precursor [Homo sapiens] [gi:15431328] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 26747753 | | CID | 2566 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1 | | AID | 900 | | BioAssay type | confirmatory | | Target | caspase-1 isoform alpha precursor [Homo sapiens] [gi:15431328] | | PubMed | | | Data Table |  |
|
| 46 | [SID26747753] | Inactive | Potency | | qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7 [AID889, Type: confirmatory] | Caspase-7 [gi:1730092] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 26747753 | | CID | 2566 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7 | | AID | 889 | | BioAssay type | confirmatory | | Target | Caspase-7 [gi:1730092] | | PubMed | | | Data Table |  |
|
| 47 | [SID26747753] | Inactive | Potency | | qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7 [AID889, Type: confirmatory] | Caspase-7 [gi:1730092] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 26747753 | | CID | 2566 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7 | | AID | 889 | | BioAssay type | confirmatory | | Target | Caspase-7 [gi:1730092] | | PubMed | | | Data Table |  |
|
| 48 | [SID26747753] | Inactive | Potency | | qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4 [AID884, Type: confirmatory] | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 26747753 | | CID | 2566 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4 | | AID | 884 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] | | PubMed | | | Data Table |  |
|
| 49 | [SID26747753] | Inactive | Potency | | qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4 [AID884, Type: confirmatory] | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 26747753 | | CID | 2566 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4 | | AID | 884 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] | | PubMed | | | Data Table |  |
|
| 50 | [SID26747753] | Inactive | Potency | | qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4 [AID884, Type: confirmatory] | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 26747753 | | CID | 2566 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4 | | AID | 884 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] | | PubMed | | | Data Table |  |
|